Subgroup | No. of studies | Participants | HR (95% CI) | P | Study heterogeneity | Analysis model | ||||
---|---|---|---|---|---|---|---|---|---|---|
RHR | RFA | Total | Χ2 | I2 (%) | P | |||||
OS | ||||||||||
 Patients in China | 7 | 559 | 695 | 1254 | 0.79 (0.65–0.95) | 0.013 | 6.11 | 1.9 | 0.410 | Fixed |
 Tumor size≦3 cm | 3 | 207 | 243 | 450 | 1.03 (0.69–1.52) | 0.897 | 0.45 | 0 | 0.799 | Fixed |
 Tumor size>3 cm | 2 | 164 | 188 | 352 | 0.57 (0.37–0.89) | 0.014 | 0.02 | 0 | 0.900 | Fixed |
PFS | ||||||||||
 Patients in China | 4 | 249 | 273 | 522 | 0.79 (0.64–0.98) | 0.029 | 0.24 | 0 | 0.971 | Fixed |
 Tumor size≦3 cm | 2 | 177 | 171 | 348 | 0.99 (0.71–1.37) | 0.929 | 0.34 | 0 | 0.563 | Fixed |